SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-348327
Filing Date
2018-12-13
Accepted
2018-12-13 08:33:00
Documents
8
Period of Report
2019-01-24
Effectiveness Date
2018-12-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d623895ddef14a.htm DEF 14A 613507
2 GRAPHIC g623895g90c41.jpg GRAPHIC 30624
3 GRAPHIC g623895page35.jpg GRAPHIC 2175
4 GRAPHIC g623895snap10.jpg GRAPHIC 1422
5 GRAPHIC g623895snap2.jpg GRAPHIC 3362
6 GRAPHIC g623895snap4.jpg GRAPHIC 961
7 GRAPHIC g623895snap6.jpg GRAPHIC 957
8 GRAPHIC g623895snap8.jpg GRAPHIC 1396
  Complete submission text file 0001193125-18-348327.txt   644605
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-14902 | Film No.: 181232233
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences